Both these tumors, however, showed a match to the methylation class “glioblastoma, IDH wildtype, subclass midline” with high calibrated scores (0.99 and 0.97, respectively), confirming the diagnosis of glioblastoma, IDH wildtype. The gene discussed is IDH2; the disease is glioblastoma.